Lianzhong Xu

Effects of depression on heart rate variability in elderly patients with stable coronary artery disease

Jinhui Wu, Ying Luo, Shaomin Zhang, 2018, Journal of evidence-based medicine.

A Theranostic Metallodrug Modulates Immunovascular Crosstalk to Combat Immunosuppressive Liver Cancer.

H. Ran, D. Guo, Jie Xu, 2022, Acta biomaterialia.

A Synergistic and Efficient Thrombolytic Nanoplatform: A Mechanical Method of Blasting Combined with Thrombolytic Drugs

H. Ran, Jun Zhou, D. Guo, 2022, International journal of nanomedicine.

Magnetic Response Combined with Bioactive Ion Therapy: A RONS-Scavenging Theranostic Nanoplatform for Thrombolysis and Renal Ischemia-Reperfusion Injury.

H. Ran, D. Guo, Jie Xu, 2023, ACS nano.

Platelet membrane-functionalized hollow mesoporous Prussian blue nanomedicine for comprehensive thrombolytic management by targeted enhanced fibrinolysis and ROS scavenging

Jia Liu, H. Ran, Jun Zhou, 2023, Chemical Engineering Journal.

Smart responsive Fe/Mn nanovaccine triggers liver cancer immunotherapy via pyroptosis and pyroptosis-boosted cGAS-STING activation

D. Guo, Jie Xu, Junrui Wang, 2024, Journal of nanobiotechnology.

Metal‐based smart nanosystems in cancer immunotherapy

Jie Xu, Yixin Zhong, Junrui Wang, 2024, Exploration.